New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
12:16 EDTAMRN, BASFYBASF acquisition a positive for Amarin, says Leerink
Leerink views BASF's (BASFY) acquisition of Pronova BioPharma a positive for Amarin (AMRN). The firm believes the deal sets a high floor value for Amarin's Vascepa and reiterates an Outperform rating on the stock with a $27 fair value estimate.
News For AMRN;BASFY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
09:00 EDTBASFYBofa/Merill special situations team to hold an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use